SCHEMBL25978142

SCHEMBL25978142

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cccc(-c5ccc(N(c6ccccc6)c6ccccc6)cc5)c34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.33
MAPT P10636 7/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 7/20 0.33
POLB P06746 1/20 0.33
HCRTR1 O43613 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
CRHR1 P34998 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26778841 0.99 ALDH1A1 (0.33) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL26778857 0.97 MAPT (0.33) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL26778850 0.95 HCRTR1 (0.35) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL26416682 0.95 MAPT (0.33) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL24255658 0.95 HCRTR1 (0.36) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL26778865 0.94 KDM4E (0.34) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL25978320 0.94 HCRTR1 (0.33) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL25978290 0.94 HCRTR1 (0.33) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL25978288 0.94 HCRTR1 (0.34) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL25926922 0.93 MAPT (0.32) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALDH1A1 9/4885MAPT 1428/4885HPGD 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.